T1	CHEM 79 88	nivolumab
#1	AnnotatorNotes T1	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T2	CHEM 91 100	sorafenib
#2	AnnotatorNotes T2	C1516119; sorafenib; Organic Chemical · Pharmacologic Substance
T3	PROC 124 135	tratamiento
#3	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	DISO 139 162	carcinoma hepatocelular
#4	AnnotatorNotes T4	C2239176; Liver carcinoma; Neoplastic Process
T5	PROC 192 236	Ensayo fase III, aleatorizado, multicéntrico
T6	CHEM 241 250	nivolumab
#5	AnnotatorNotes T6	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T7	CHEM 260 269	sorafenib
#6	AnnotatorNotes T7	C1516119; sorafenib; Organic Chemical · Pharmacologic Substance
T8	PROC 276 304	tratamiento de primera línea
#7	AnnotatorNotes T8	C1708063; First line treatment; Therapeutic or Preventive Procedure
T9	DISO 322 345	carcinoma hepatocelular
#8	AnnotatorNotes T9	C2239176; Liver carcinoma; Neoplastic Process
T10	DISO 376 399	Carcinoma Hepatocelular
#9	AnnotatorNotes T10	C2239176; Liver carcinoma; Neoplastic Process
T11	DISO 427 450	Carcinoma hepatocelular
#10	AnnotatorNotes T11	C2239176; Liver carcinoma; Neoplastic Process
T12	PROC 506 550	tratamientos quirúrgicos y/o locorregionales
T13	DISO 554 575	enfermedad progresiva
T14	PROC 587 630	tratamientos quirúrgicos y/o locoregionales
T15	PROC 637 662	tratamiento locorregional
T16	DISO 671 674	CHC
#11	AnnotatorNotes T16	C2239176; Liver carcinoma; Neoplastic Process
T17	PROC 727 744	estudio de imagen
#12	AnnotatorNotes T17	C1881134; imaging studies; Diagnostic Procedure
T18	DISO 900 916	CHC fibrolamelar
#13	AnnotatorNotes T18	C0334287; Fibrolamellar Hepatocellular Carcinoma; Neoplastic Process
T19	DISO 918 934	CHC sarcomatoide
#14	AnnotatorNotes T19	C1710014; Sarcomatoid Hepatocellular Carcinoma; Neoplastic Process
T20	DISO 937 972	tumor mixto colangiocarcinoma y CHC
#15	AnnotatorNotes T20	C0221287; Combined Hepatocellular Carcinoma and Cholangiocarcinoma; Neoplastic Process
T21	DISO 1015 1036	Enfermedad autoinmune
#16	AnnotatorNotes T21	C0004364; Autoimmune Diseases; Disease or Syndrome
T22	PROC 986 1005	Trasplante hepático
#17	AnnotatorNotes T22	C0023911; Transplantation of liver; Therapeutic or Preventive Procedure
T23	ANAT 149 162	hepatocelular
#18	AnnotatorNotes T23	C0227525; Hepatocyte; Cell
T24	ANAT 332 345	hepatocelular
#19	AnnotatorNotes T24	C0227525; Hepatocyte; Cell
T25	ANAT 386 399	Hepatocelular
#20	AnnotatorNotes T25	C0227525; Hepatocyte; Cell
T26	ANAT 437 450	hepatocelular
#21	AnnotatorNotes T26	C0227525; Hepatocyte; Cell
T27	DISO 754 770	Estado cirrótico
T28	ANAT 997 1005	hepático
#22	AnnotatorNotes T28	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T29	Date 13 17	2015
T31	LIVB 308 317	pacientes
#23	AnnotatorNotes T31	C0030705; Patients; Patient or Disabled Group
T32	Neg_cue 489 491	no
T33	Duration 698 716	al menos 4 semanas
T35	Spec_cue 1056 1066	sospechada
T30	PROC 774 784	Child-Pugh
#24	AnnotatorNotes T30	C3854424; Child-Pugh-Turcotte score; Laboratory Procedure
T34	PROC 795 811	Estado funcional
#25	AnnotatorNotes T34	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T36	PROC 461 477	histológicamente
#26	AnnotatorNotes T36	C0344441; Histology Procedure; Laboratory Procedure
T37	PROC 813 815	EF
#27	AnnotatorNotes T37	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
A1	Assertion T12 Negated
A2	Assertion T21 Speculated
A3	Status T22 History_of
A4	Status T15 History_of
A5	Status T20 History_of
A6	Status T19 History_of
A7	Status T18 History_of
A8	Status T21 History_of
#28	AnnotatorNotes T5	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C1096776; Multicenter Study; Research Activity
#29	AnnotatorNotes T13	C1335499; Progressive Disease; Disease or Syndrome 
#30	AnnotatorNotes T27	C1623038; Cirrhosis; Disease or Syndrome
R1	Used_for Arg1:T2 Arg2:T3	
R2	Used_for Arg1:T1 Arg2:T3	
R3	Location_of Arg1:T23 Arg2:T4	
R4	Location_of Arg1:T24 Arg2:T9	
T38	Quantifier_or_Qualifier 163 171	avanzado
#31	AnnotatorNotes T38	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R5	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T38	
T39	Quantifier_or_Qualifier 346 354	avanzado
#32	AnnotatorNotes T39	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R6	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T39	
R7	Location_of Arg1:T25 Arg2:T10	
R8	Location_of Arg1:T26 Arg2:T11	
T40	Quantifier_or_Qualifier 451 459	avanzado
#33	AnnotatorNotes T40	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R9	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T40	
R11	Experiences Arg1:T31 Arg2:T6	
R12	Experiences Arg1:T31 Arg2:T7	
R13	Used_for Arg1:T7 Arg2:T8	
R14	Used_for Arg1:T6 Arg2:T8	
R15	Experiences Arg1:T31 Arg2:T9	
R16	Negation Arg1:T32 Arg2:T12	
R17	After Arg1:T13 Arg2:T14	
T41	Quantifier_or_Qualifier 688 697	terminado
#34	AnnotatorNotes T41	C1272693; Ended - status; Qualitative Concept
R18	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T41	
R19	Overlap Arg1:T41 Arg2:T33	
R20	Before Arg1:T41 Arg2:T17	
R21	Before Arg1:T15 Arg2:T17	
T42	Quantifier_or_Qualifier 745 750	basal
#35	AnnotatorNotes T42	C1442488; Baseline; Quantitative Concept
R22	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T42	
T43	Result_or_Value 785 792	Clase A
R23	Has_Result_or_Value Arg1:T30 Arg2:T43	
T44	CONC 821 855	Eastern Cooperative Oncology Group
#36	AnnotatorNotes T44	C1520224; ECOG performance status; Intellectual Product
R24	Used_for Arg1:T44 Arg2:T37	
R25	Used_for Arg1:T44 Arg2:T34	
T45	CONC 857 861	ECOG
#37	AnnotatorNotes T45	C1520224; ECOG performance status; Intellectual Product
R26	Used_for Arg1:T45 Arg2:T37	
R27	Used_for Arg1:T45 Arg2:T34	
T46	Result_or_Value 866 871	0 o 1
R28	Has_Result_or_Value Arg1:T45 Arg2:T46	
R29	Has_Result_or_Value Arg1:T44 Arg2:T46	
R30	Location_of Arg1:T28 Arg2:T22	
R31	Speculation Arg1:T35 Arg2:T21	
T47	Quantifier_or_Qualifier 1037 1043	activa
#38	AnnotatorNotes T47	C0679217; Active State; Idea or Concept
R32	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T47	
R33	Location_of Arg1:T26 Arg2:T13	
T48	Spec_cue 76 78	si
T49	Quantifier_or_Qualifier 104 116	más efectivo
A9	Assertion T49 Speculated
A10	Assertion T1 Speculated
A11	Assertion T2 Speculated
R34	Speculation Arg1:T48 Arg2:T1	
R35	Speculation Arg1:T48 Arg2:T2	
R36	Speculation Arg1:T48 Arg2:T49	
R37	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T49	
R38	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T49	
#39	AnnotatorNotes T15	C1517925; Local Therapy; Therapeutic or Preventive Procedure (?)
#40	AnnotatorNotes T14	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure | C1517925; Local Therapy; Therapeutic or Preventive Procedure (?)
#41	AnnotatorNotes T12	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure | C1517925; Local Therapy; Therapeutic or Preventive Procedure (?)
A12	Experiencer T31 Patient
